Crispr Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.1M | 48k | 64.81 |
| 2025-06-30 | $2.4M | 49k | 48.64 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors